Gapping up
In reaction to strong earnings/guidance:
- RELL +21.9%, PRGS +8.8%, FCEL +8.1%, DAL +3.7%, KBH +3.4%, EMMS +2.6%
Other news:
- SECO +37.4% (mention of blockchain; Company is a similar business model to EBAY and is based in China)
- MEIP +13.8% (MEI Pharma and Helsinn Group receive Orphan Drug Designation for Pracinostat from the European Medicines Agency)
- ARDM +12.3% (Aradigm lower with LPCN and ahead of its own meeting with the FDA Antimicrobial Drugs Advisory Committee)
- DPW +7.4% (after closing up nearly 40% on the day)
- FNJN +6.4% ( ticking higher after Federal Circuit affirms Finjan's patents)
- TANH +4.9% (Tantech to acquire shares of Shanghai Shicai subsidiary Lishui Xincai for RMB120 mln)
- MFIN +2.6% (continued strength)
- AMD +1% (Advanced Micro and JD.com collaborate to expand availability of AMD Ryzen desktop processors in China)
Analyst comments:
- EXPE +3.4% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- Z +3.3% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- RH +2.8% (upgraded to Buy from Hold at Loop Capital)
- RCL +1% (upgraded to Buy from Hold at Berenberg)
- NFLX +0.8% (initiated with a Overweight at Barclays)
